EPSTEIN–BARR VIRUS IN THE POPULATION OF TWO GEOGRAPHICALLY DIFFERENT REGIONS OF RUSSIA

Código QR

EPSTEIN–BARR VIRUS IN THE POPULATION OF TWO GEOGRAPHICALLY DIFFERENT REGIONS OF RUSSIA

It is well known that the Epstein–Barr virus (EBV) being widely spread in the human population is also the etiologic agent for a number of malignancies. A notable feature of tumors associated with EBV is their different incidence in various geographical regions, that, as suggested, related with muta...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	N. B. Senyuta, A. V. Ignatova, M. V. Lomaya, E. V. Goncharova, L. N. Scherback, T. E. Dushenkina, D. V. Gugunov, A. M. Mudunov, V. E. Gurtsevitch
Formato:	article
Lenguaje:	RU
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2017
Materias:	epstein–barr virus antibody response nasopharyngeal cancer lmp1 oncogene Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/636d6f8035e447ad84d915bb384984b8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma
por: Qian-Ying Zhu, et al.
Publicado: (2020)

Identifying Epstein–Barr virus peptide sequences associated with differential IgG antibody response
por: Anna E. Coghill, et al.
Publicado: (2022)

Epstein–Barr virus LMP1 oncogene polymorphism in tatar and slavic populations in Russian Federation impacting on some malignant tumours
por: V. E. Gurtsevitch, et al.
Publicado: (2020)

Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction
por: Jing Cai, et al.
Publicado: (2021)

Epstein-Barr Virus LMP1 Promotes Syntenin-1- and Hrs-Induced Extracellular Vesicle Formation for Its Own Secretion To Increase Cell Proliferation and Migration
por: Dingani Nkosi, et al.
Publicado: (2020)

THE MODERN CONCEPTIONS ABOUT IMMUNOPATHOGENESIS OF INFECTION CAUSED BY THE EPSTEIN–BARR VIRUS
por: T. V. Goreiko, et al.
Publicado: (2014)

Epstein-Barr Virus Induces Adhesion Receptor CD226 (DNAM-1) Expression during Primary B-Cell Transformation into Lymphoblastoid Cell Lines
por: Lisa Grossman, et al.
Publicado: (2017)

Competitive Endogenous RNA Landscape in Epstein-Barr Virus Associated Nasopharyngeal Carcinoma
por: Xiandong Lin, et al.
Publicado: (2021)

PRESENCIA DEL MARCADOR LMP-1 DEL VIRUS EPSTEIN-BARR EN LINFOMAS DE CANINOS
por: L. C. Veloza, et al.
Publicado: (2017)

mSphere of Influence: 3-D Culture Models Influence Studies on Epstein-Barr Virus Molecular Pathogenesis in the Epithelium
por: K. H. Y. Shair
Publicado: (2020)

Two Pathways of p27<sup>Kip1</sup> Degradation Are Required for Murine Lymphoma Driven by Myc and EBV Latent Membrane Protein 2A
por: Richard P. Sora, et al.
Publicado: (2019)

Convulsiones y paro cardiaco: forma inhabitual de presentación de miocarditis asociada a virus de Epstein Barr
por: Mericq G,Verónica, et al.
Publicado: (1993)

Falla hepática fulminante por virus Epstein Barr: Rol de los corticoides. Caso clínico
por: VIVIANI G,PAULA, et al.
Publicado: (2013)

Características clínico-moleculares del cáncer gástrico cardial asociado al virus Epstein Barr
por: Corvalán R,Alejandro, et al.
Publicado: (2005)

Inmunohistoquímica en un caso de encefalitis por virus de Epstein Barr
por: Calore,Edenilson E, et al.
Publicado: (2012)

Latent Membrane Protein 1 Is a Novel Determinant of Epstein-Barr Virus Genome Persistence and Reactivation
por: Elizabeth A. Caves, et al.
Publicado: (2017)

CLINICAL-IMMUNOLOGY EFFICIENCY OF CONSERVATIVE TREATMENT OF PATIENTS WITH CHRONIC TONSILLITIS ASSOCIATED WITH EPSTEIN - BARR VIRUS INFECTION
por: A. S. Krasnitskaja, et al.
Publicado: (2012)

Epstein-Barr Virus-Associated Carcinoma of the Larynx: A Systematic Review with Meta-Analysis
por: Marcos Antonio Pereira de Lima, et al.
Publicado: (2021)

Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions
por: Alessio Buonavoglia, et al.
Publicado: (2021)

Phagocytic activity of neutrophils and monocytes in patients with reactive arthritis caused by Epstein-Barr viral and chlamydial infections
por: M.P. Lomikovska, et al.
Publicado: (2019)

Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality
por: Sara R. Selitsky, et al.
Publicado: (2018)

Identification of Host Biomarkers of Epstein-Barr Virus Latency IIb and Latency III
por: Joshua E. Messinger, et al.
Publicado: (2019)

Importance of Epstein–Barr virus infection in pathogenesis of proliferative complications in children with endogenous uveitis
por: M. S. Petrovskaya, et al.
Publicado: (2020)

A case of Epstein Barr virus-associated primary squamous cell carcinoma of stomach
por: Yuki Katsura, et al.
Publicado: (2021)

Air-Liquid Interface Method To Study Epstein-Barr Virus Pathogenesis in Nasopharyngeal Epithelial Cells
por: Elizabeth A. Caves, et al.
Publicado: (2018)

CONTENTS OF IL-1Β, IL-RA, IL-4, IL-8 AND IFNΓ IN THE CHILDREN WITH MINOR CLINICAL FORMS OF TUBERCULOSIS INFECTED WITH TOXOPLASMA GONDII AND EPSTEIN–BARR VIRUS
por: A. V. Kalityn, et al.
Publicado: (2014)

Clinical and immunological efficiency of different therapy regimens in patients with infectious mononucleosis caused by Epstein-Barr virus
por: Pavlikova Ksenia, et al.
Publicado: (2021)

IN VITRO CELLULAR RESPONSE TO INTERFERON-α2 IN CHILDREN WITH INFECTIOUS MONONUCLEOSIS CAUSED BY EPSTEIN-BARR VIRUS
por: L. M. Kurtasova, et al.
Publicado: (2016)

Associação do vírus Epstein-Barr (EBV) com tumores sólidos
por: Marcos Antonio Pereira de Lima, et al.
Publicado: (2006)

Endoscopic and pathologic motifs for the clinical diagnosis of Epstein–Barr virus‐associated gastric cancer
por: Hideo Yanai, et al.
Publicado: (2021)

Clinical and Therapeutic Implications of Epstein–Barr Virus in HIV-Related Lymphomas
por: Miriam Verdu-Bou, et al.
Publicado: (2021)

Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a postpartum patient with preeclampsia: a case report
por: Bruce Lee, MD, et al.
Publicado: (2021)

INFLUENCE OF CYCLOFERON ON THE CELLULAR SUSCEPTIBILITY TO INTERFERON-α2 IN VITRO IN PATIENTS WITH INFECTIOUS MONONUCLEOSIS CAUSED BY EPSTEIN– BARR VIRUS
por: L. M. Kurtasova, et al.
Publicado: (2018)

Epstein-Barr Virus-Positive Adrenal Diffuse Large B-Cell Lymphoma after Treatment for Angioimmunoblastic T-Cell Lymphoma
por: Akiko Hashimoto, et al.
Publicado: (2021)

Epstein–Barr Virus+ B Cells in Breast Cancer Immune Response: A Case Report
por: Andrea Aran, et al.
Publicado: (2021)

Clinical diagnostic criteria of efficiency for combined etiopathogenetic therapy in patients with chronic Epstein–Barr virus infection
por: V. A. Zurochka, et al.
Publicado: (2020)

MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control <italic toggle="yes">In Vivo</italic>
por: Anita Murer, et al.
Publicado: (2019)

Metagenomic Next-Generation Sequencing for the Diagnosis of Epstein-Barr virus Pleurisy: A Case Report
por: Hui Lv, et al.
Publicado: (2021)

Rare case of Visceral form of Infectious Mononucleosis in Irkutsk Region
por: N. K. Bobrova, et al.
Publicado: (2019)

Epstein-Barr Virus Epitope–Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor α and β Repertoires
por: Anna Gil, et al.
Publicado: (2020)